by Christine Woolstenhulme, QMC QCC CMCS CPC CMRS
Feb 9th, 2015 - Reviewed/Updated Aug 9th
Physician Office: Coding And Billing For JETREA®
The information contained below is provided for informational purposes only and is not intended to provide specific guidance on how to code, bill, or charge for any product or service. The following list provides possible codes that may relate to the use of JETREA for its approved indication and is not intended to be comprehensive. It is the sole responsibility of the provider to select proper coding for rendered products or services and to ensure the accuracy of all claims used in seeking reimbursement. ThromboGenics cannot guarantee payment of any claim.
| Classification Category | Coding System | Code | Description | Notes |
|---|---|---|---|---|
| Diagnosis | ICD-9-CM1 | 379.27* | Vitreomacular adhesion, vitreomacular traction |
|
| Administration Procedure | CPT Code | 67028 | Intravitreal injection of a pharmacologic agent2 |
|
| Drug Code | HCPCS | NEW: J7316† Effective 1/1/14 |
Injection, Ocriplasmin, 0.125 mg3 |
|
| C9298‡ | Injection, Ocriplasmin, 0.125 mg4 |
|
||
| NDC | 24856-0001-00 | One single-use vial of JETREA5 |
|
Enroll your patients in JETREA CARE to determine eligibility for our patient assistance programs
*Excludes traction detachment with vitreoretinal organization (361.81).
†Effective as of January 1, 2014
‡Effective as of April 1, 20134
References/Resources
About Christine Woolstenhulme, QMC QCC CMCS CPC CMRS
Christine Woolstenhulme, CPC, QCC, CMCS, CMRS, is a Certified coder and Medical Biller with 30 years of experience in the healthcare industry.
Quick, Current, Complete - www.findacode.com